CX Institutional Buys 54,747 Shares of Colgate-Palmolive (NYSE:CL)

CX Institutional boosted its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 1,206.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 59,286 shares of the company's stock after acquiring an additional 54,747 shares during the quarter. CX Institutional's holdings in Colgate-Palmolive were worth $5,555,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Assenagon Asset Management S.A. lifted its holdings in Colgate-Palmolive by 107.3% during the 1st quarter. Assenagon Asset Management S.A. now owns 1,072,742 shares of the company's stock valued at $100,516,000 after purchasing an additional 555,216 shares during the last quarter. Sarasin & Partners LLP lifted its stake in shares of Colgate-Palmolive by 9.5% during the 1st quarter. Sarasin & Partners LLP now owns 3,874,593 shares of the company's stock worth $363,049,000 after buying an additional 336,737 shares during the last quarter. SG Americas Securities LLC lifted its stake in shares of Colgate-Palmolive by 1,872.4% during the 1st quarter. SG Americas Securities LLC now owns 180,007 shares of the company's stock worth $16,867,000 after buying an additional 190,163 shares during the last quarter. Curated Wealth Partners LLC bought a new stake in shares of Colgate-Palmolive during the 1st quarter worth about $993,000. Finally, Abacus FCF Advisors LLC grew its stake in Colgate-Palmolive by 66.5% in the 1st quarter. Abacus FCF Advisors LLC now owns 162,163 shares of the company's stock valued at $15,195,000 after buying an additional 64,742 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Analyst Ratings Changes

CL has been the subject of a number of research analyst reports. Wells Fargo & Company boosted their price objective on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a report on Wednesday, April 2nd. JPMorgan Chase & Co. upped their price objective on Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a report on Monday, April 28th. Barclays reduced their target price on shares of Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a research report on Friday, April 11th. Piper Sandler lowered their price target on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research report on Monday, March 31st. Finally, UBS Group boosted their price objective on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a report on Thursday, April 17th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $102.12.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock traded up $0.15 during mid-day trading on Thursday, reaching $92.26. The company had a trading volume of 1,860,357 shares, compared to its average volume of 4,729,365. The business has a fifty day simple moving average of $91.64 and a 200 day simple moving average of $91.13. The company has a market cap of $74.77 billion, a P/E ratio of 26.21, a P/E/G ratio of 4.20 and a beta of 0.38. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The company had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.92 billion. During the same quarter in the prior year, the firm posted $0.86 earnings per share. The firm's revenue was down 3.0% compared to the same quarter last year. On average, equities research analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th were given a $0.52 dividend. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a yield of 2.25%. The ex-dividend date was Thursday, April 17th. Colgate-Palmolive's dividend payout ratio is 58.76%.

Colgate-Palmolive declared that its Board of Directors has approved a share repurchase program on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 6.8% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's board believes its shares are undervalued.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.